OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22
Sen Chen, Shuangxin Ma, Jiaoyan Yan, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 8
Sen Chen, Shuangxin Ma, Jiaoyan Yan, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 8
Showing 8 citing articles:
Recruitment of FBXO22 for targeted degradation of NSD2
Yan Nie, John R. Tabor, Jianping Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1597-1607
Closed Access | Times Cited: 16
Yan Nie, John R. Tabor, Jianping Li, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 12, pp. 1597-1607
Closed Access | Times Cited: 16
A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo
Zhizhou Wang, Qihang Yuan, Xu Chen, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Open Access | Times Cited: 20
Zhizhou Wang, Qihang Yuan, Xu Chen, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Open Access | Times Cited: 20
Dual BACH1 regulation by complementary SCF-type E3 ligases
Benedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
Cell (2024)
Closed Access | Times Cited: 4
Benedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
Cell (2024)
Closed Access | Times Cited: 4
FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer
Yuehua Zhang, Wen Li, Shenghu Guo, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 9, pp. 1248-1266
Open Access | Times Cited: 7
Yuehua Zhang, Wen Li, Shenghu Guo, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 9, pp. 1248-1266
Open Access | Times Cited: 7
He Zhang, Yang Bai, Jiatong Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 1
FBXO22 is a potential therapeutic target for recurrent chondrosarcoma
Baoquan Xin, Hui Chen, Zhi Zhu, et al.
Journal of bone oncology (2024) Vol. 46, pp. 100605-100605
Open Access | Times Cited: 1
Baoquan Xin, Hui Chen, Zhi Zhu, et al.
Journal of bone oncology (2024) Vol. 46, pp. 100605-100605
Open Access | Times Cited: 1
Recruitment of FBXO22 for Targeted Degradation of NSD2
Yan Nie, John R. Tabor, Jianping Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Yan Nie, John R. Tabor, Jianping Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Pyridoxal kinase (PDXK) facilitates CRC progression by releasing beta-catenin from the GSK-3β destruction complex
Mengqi Fan, Mengqi Fan, Jie Gao, et al.
Research Square (Research Square) (2023)
Open Access
Mengqi Fan, Mengqi Fan, Jie Gao, et al.
Research Square (Research Square) (2023)
Open Access
